More about

Drug Interaction

News
March 16, 2022
2 min read
Save

AHA guidance identifies potential drug-to-drug interactions between CV, cancer medications

In a recent American Heart Association scientific statement, a committee provided an overview of drug-to-drug interactions between cancer drugs and commonly used CV medications.

News
March 22, 2021
2 min read
Save

Many older adults prescribed thyroid hormone plus drugs that interfere with thyroid tests

Nearly one-third of older adults on thyroid hormone also take another medication that can interfere with thyroid function tests, particularly adults with multiple comorbidities, according to data presented at the ENDO annual meeting.

News
October 07, 2020
2 min read
Save

Most older adults have not had comprehensive medication review

Among older adults taking at least two prescription medications, just one in four had a comprehensive mediation review with their pharmacist, according to findings from the National Poll on Healthy Aging conducted by the University of Michigan.

News
September 17, 2020
2 min read
Save

Azithromycin with QT-prolonging drugs may elevate cardiac event risk

According to findings published in JAMA Network Open, the combination of azithromycin and QT-prolonging drugs was associated with a 40% increase in cardiac events compared with amoxicillin and QT-prolonging drugs.

News
June 29, 2020
4 min read
Save

Q&A: Navigating drug interactions crucial in patients with AF, COVID-19

Therapies for patients who present with COVID-19 may interact with drugs used to treat arrhythmias such as atrial fibrillation, which poses challenges for clinicians.

News
January 16, 2020
5 min read
Save

A look at the interaction between opioids and oral P2Y12 inhibitors

A recently recognized drug-drug interaction between opioids and P2Y12 inhibitors may have clinical implications for patients with ACS.

News
November 22, 2019
2 min read
Save

Trio Health presents novel HBV, HCV therapy findings at The Liver Meeting

Trio Health presented results from four studies at The Liver Meeting 2019 that showed novel outcomes in patients treated for hepatitis B with Vemlidy or hepatitis C with Vosevi.